Stem cells from surgery leftovers could repair damaged hearts
Press release issued: 26 April 2010
Scientists from the Bristol Heart Institute (BHI) at the University of Bristol have for the first time succeeded in extracting vital stem cells from sections of vein removed for heart bypass surgery.
The research, by Paolo Madeddu, Professor of Experimental Cardiovascular Medicine and his team in the Bristol Heart Institute (BHI) at the University of Bristol, is published in the leading journal Circulation.
Around 20,000 people each year undergo heart bypass surgery. The procedure involves taking a piece of vein from the person’s leg and grafting it onto a diseased coronary artery to divert blood around a blockage or narrowing.
The surgeon normally takes out a longer section of vein than is needed for the bypass. The Bristol team successfully isolated stem cells from leftover veins that patients had agreed to donate.
In tests in mice, the cells proved able to stimulate new blood vessels to grow into injured leg muscles. Professor Madeddu and his team are now beginning to investigate whether the cells can help the heart to recover from a heart attack.
“This is the first time that anyone has been able to extract stem cells from sections of vein left over from heart bypass operations,” Professor Madeddu said. “These cells might make it possible for a person having a bypass to also receive a heart treatment using their body’s own stem cells.
“We can also multiply these cells in the lab to make millions more stem cells, which could potentially be stored in a bank and used to treat thousands of patients.”
Professor Peter Weissberg, Medical Director of the BHF, said: “Repairing a damaged heart is the holy grail for heart patients. The discovery that cells taken from patients’ own blood vessels may be able to stimulate new blood vessels to grow in damaged tissues is a very encouraging and important advance. It brings the possibility of ‘cell therapy’ for damaged hearts one step closer and, importantly, if the chemical messages produced by the cells can be identified, it is possible that drugs could be developed to achieve the same end.”
Further informationP Campagnolo et al (2010) ‘Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential’. Circulation 121:1735-1745.
The British Heart Foundation (BHF) is the nation’s heart charity, dedicated to saving lives through pioneering research, patient care, campaigning for change and by providing vital information. But we urgently need help. We rely on donations of time and money to continue our life-saving work. Because together we can beat heart disease.
The Bristol Heart Institute (BHI) is made up of over 200 researchers and clinicians, from eight different departments in the University of Bristol, spanning three faculties, and from associated Bristol NHS Trusts. Research income is generated from grants, with the British Heart Foundation being the Institute’s main funder. As well as improving collaboration between scientists and clinicians within the Institute, the aim is to communicate research findings to the public.